ARMC5 and adrenal cortex carcinoma: In vitro experiments show ARMC5 missense variants identified in human adrenocortical cancer cell line (H295R), leads to loss of apoptosis activity,13 suggesting that these variants affect ARMC5’s pro‐apoptotic function.